GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Total Debt per Share

BioGend Therapeutics Co (ROCO:6733) Total Debt per Share : NT$0.08 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioGend Therapeutics Co Total Debt per Share?

NT$0.08 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. BioGend Therapeutics Co's Total Debt Per Share for the quarter that ended in Dec. 2024 was NT$0.08.

BioGend Therapeutics Co Total Debt per Share Historical Data

The historical data trend for BioGend Therapeutics Co's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGend Therapeutics Co Total Debt per Share Chart

BioGend Therapeutics Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only - 0.04 0.15 0.11 0.08

BioGend Therapeutics Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.10 0.09 0.08 0.08

BioGend Therapeutics Co Total Debt per Share Calculation

BioGend Therapeutics Co's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(5.8+3.6)/124.3
=0.08

BioGend Therapeutics Co's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(5.8+3.6)/124.3
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGend Therapeutics Co Total Debt per Share Related Terms

Thank you for viewing the detailed overview of BioGend Therapeutics Co's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGend Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioGend Therapeutics Co Ltd (ROCO:6733) » Definitions » Total Debt per Share
Comparable Companies
ROCO:7808 ROCO:1777 TPE:6885 TPE:6794 ROCO:6492 ROCO:06891 ROCO:6808 ROCO:6634 ROCO:6461 ROCO:6945 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
Yuanqu Street, 4th Floor, Number 3-2, Nangang District, Taipei, TWN, 115
Website
https://www.biogend.com.tw
BioGend Therapeutics Co Ltd is a Taiwan-based company involved in the research and development of orthopedic medical equipment and related products and the sale of related products. It is involved in the research and development of innovative cartilage repair technology and products, adipose stem cell extraction technology, and others. Geographically, the company generates a majority of its revenue from Taiwan followed by China and other regions.

BioGend Therapeutics Co Headlines

No Headlines